Collegium Pharmaceutical (COLL) Shares Outstanding (Diluted Average) (2019 - 2026)

Collegium Pharmaceutical's Shares Outstanding (Diluted Average) history runs 6 years deep, the most recent figure standing at $40.1 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) rose 22.0% year-over-year to $40.1 million; the TTM figure through Mar 2026 stood at $40.1 million (up 22.0% YoY), while the FY2025 annual figure was $40.1 million, down 0.86% from the prior year.
• Shares Outstanding (Diluted Average) was $40.1 million for Q1 2026 at Collegium Pharmaceutical, roughly flat from $40.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $41.8 million in Q4 2023 to a low of $32.8 million in Q1 2025.
• Historically, Shares Outstanding (Diluted Average) has averaged $39.6 million across 4 years, with a median of $40.1 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Diluted Average) decreased 20.75% in 2025, then grew 22.0% in 2026.
• A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $41.8 million in 2023, then declined by 3.26% to $40.4 million in 2024, then slipped by 0.86% to $40.1 million in 2025, then decreased by 0.03% to $40.1 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $40.1 million (Q1 2026), $40.1 million (Q4 2025), and $39.4 million (Q3 2025), per Business Quant data.